Larry A. Harshyne, Ph.D.
Affiliations: | 2002 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
ImmunologyGoogle:
"Larry Harshyne"Parents
Sign in to add mentor| Simon M. Barratt-Boyes | grad student | 2002 | University of Pittsburgh | |
| (Antigen acquisition by dendritic cells: A focus on transfer between live cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Herbst C, Harshyne LA, Igyártó BZ. (2022) Intracellular monitoring by dendritic cells - a new way to stay informed - from a simple scavenger to an active gatherer. Frontiers in Immunology. 13: 1053582 |
| Flemming JP, Hill BL, Haque MW, et al. (2020) miRNA- and cytokine-associated extracellular vesicles mediate squamous cell carcinomas. Journal of Extracellular Vesicles. 9: 1790159 |
| Luginbuhl A, Johnson JM, Harshyne L, et al. (2020) Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 38: TPS6595-TPS6595 |
| Zinner R, Axelrod R, Solomides CC, et al. (2020) Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC. Journal of Clinical Oncology. 38: 9051-9051 |
| Zinner R, Johnson JM, Tuluc M, et al. (2020) Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) in resectable locally advanced head and neck cancer. Journal of Clinical Oncology. 38: 6583-6583 |
| Johnson JM, Bar Ad V, Lorber E, et al. (2020) Nivolumab (Nivo) and ipilimumab (Ipi) in combination with radiotherapy (RT) in high-risk patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN). Journal of Clinical Oncology. 38: 6577-6577 |
| Judy KD, Andrews DW, Harshyne L, et al. (2020) Abstract B71: Phase 1b/2 prospective randomized trial of four autologous cell vaccine dose cohorts for initial treatment of glioblastoma Cancer Immunology Research. 8 |
| Lin J, Song AJ, Hoffman-Censits J, et al. (2019) A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer. American Journal of Clinical Oncology |
| Kumar AT, Knops A, Swendseid B, et al. (2019) Prognostic Significance of Tumor-Associated Macrophage Content in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis. Frontiers in Oncology. 9: 656 |
| Topf MC, Harshyne L, Tuluc M, et al. (2019) Loss of CD169 Subcapsular Macrophages during Metastatic Spread of Head and Neck Squamous Cell Carcinoma. Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery. 194599819829741 |